Thursday 10 April 2014

Doravirine, MK-1439 reverse transcriptase inhibitor In Phase 3 for treatment of HIV-1 infection « New Drug Approvals

Doravirine, MK-1439 reverse transcriptase inhibitor In Phase 3 for treatment of HIV-1 infection « New Drug Approvals:



'via Blog this'

No comments:

Post a Comment